Rha, S. Y., Kang, B., Jeung, H., Jung, M., Chon, H. J., Kim, J., Cha, H., Kwon, H., Hong, H., Kim, J. (2026). A multicenter, open-label, single-arm, dose-finding and -expansion phase 1b/2 study to evaluate the safety and tolerability of nesuparib (JPI-547) in combination with irinotecan as a third-line and beyond therapy for recurrent or metastatic gastric cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps4247